Market Analysis of Global Pharmaceutical Industries and Trend Estimation Featuring Pfizer, J&J, Abbott, Gilead, Sun Pharma, GSK and Eli Lilly
Research and Markets has announced the addition of the "Market Analysis Of Global Pharmaceutical Industries And Trend Estimation" report to their offering.
The report analyses the global trend of pharmaceutical industries. It gives vivid profile of generic drugs and emerging market across the globe. A comprehensive market analysis of Germany, Russia, US, Australia, China and India has been presented. Analysis covers market capacity, market value, drug consumption, healthcare expenditure, export and import of drugs, retail commercial market, hospital sale, key achievements and developments, markets around different kinds of drugs etc. The report presents financial analysis of top pharmaceutical companies such as Pfizer, Johnson and Johnson, Abbott, Gilead, Sun Pharma, Glaxo Smith Kline, Eli Lilly & Company.
The latest annual reports of all companies were analysed and compared with earlier reports so as to decipher market trends. Key issues involved in pharmaceutical supply chain for optimization have been identified. Management, discussion and analysis reports of global pharmaceutical industries are an added feature of this report. The future global market trend for coming years has been predicted in light of enormous data collected from various sources.
Key Topics Covered:
1. Pharmaceutical And Pharmaceutical Company
1.1 Pharmaceutical Company
1.2 Definition Of Medicinal Product Or Drug
1.3 Classification Of Drugs
1.4 History Of Drugs
1.5 Ancient Pharmacology
1.6 Medieval Pharmacology
1.7 Modern Pharmacology
1.8 Drugs And Intellectual Property Rights
2. Generic Industry
2.1 Generic Industry
2.2 Introduction To The Generic Market
2.3 Leading Companies In The Generic Industry
2.4 The Generic Industry And Mergers & Acquisitions
2.5 Generic Industry & Emerging Markets
2.6 Conclusion To The Generics Industry
3. Pharmaceutical Industries In Selected Countries Of The World
3.1 German Pharmaceutical Industry
3.2 Russian Pharmaceutical Market
3.3 Russian Pharma Company
3.4 Russian Pharmaceuticals Market
3.5 Us Pharmaceuticals Market
3.6 Australia Pharmaceuticals Industry
3.7 China Pharmaceuticals Industry
3.8 Indian Pharmaceuticals Industry
4. Financial Analysis Of Top Pharmaceutical Companies
4.1 Pfizer
4.2 Johnson & Johnson
4.3 Abbott Pharmaceuticals
4.4 Gilead
4.5 Sun Pharma
4.6 Glaxo Smith Kline Annual Report
4.7 Eli Lilly & Company Annual Report
5. Pharmaceutical Supply Chains: Key Issues And Strategies For Optimisation
5.1 Trends In The Pharmaceutical And Related Industries
5.2 Value Chains
5.3 Supply Chains
5.4 Process, Development & Design
5.5 Optimised Planning Of Tests
5.6 Capacity And Portfolio Planning Under Uncertainty
5.7 Combined Testing And Capacity Planning
5.8 Classical Supply Chain Planning And Management
5.9 Issues/Structure
5.10 Dynamic Supply Chain Analysis
5.11 A Particular Market
5.12 Comparison Of Two Supply Chain Responses
5.13 Some Conclusions
5.14 Future Perspectives
6. Management, Discussion And Analysis Report Of Global Pharma Industry
7. Summary
Related News
-
News Pharmaceutical Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain.
-
News Merck KGaA to buy US biotech SpringWorks for US$3.9 billion
The German multinational pharmaceutical company Merck KGaA have signed a deal to buy US biotech company SpringWorks Therapeutics at an equity value of US$3.9 billion in a move to add rare cancer therapeutics to their pipelines.
-
News Cassava Sciences halts Alzheimer's drug trial after limited progress
Cassava Sciences have drawn a close to their investigations and development of the drug simufilam, which they intended to be used for the treatment of Alzheimer’s disease.
-
News US FDA adds haemodialysis bloodlines to devices shortage list
On March 14, 2025, the US FDA published an open letter to healthcare providers citing continuing supply disruptions of haemodialysis bloodlines, an essential component of dialysis machines.
-
News Vertex Pharmaceuticals stock jumps as FDA approves non-opioid painkiller
UK-based Vertex Pharmaceuticals saw their stock shares soar as the US FDA signed off on the non-opioid painkiller Journavx, also known as suzetrigine, for patients with moderate to severe acute pain, caused by surgery, accidents, or injuries.
-
News Lessons from CPHI Milan 2024: Sunny Intervals for Pharma Manufacturing?
As the 2024 CPHI conference wrapped up in Milan, we caught up with L.E.K. Consulting – a global strategy consulting firm with deep expertise in pharma manufacturing – to discuss evolving market perspectives and business outlook. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement.